Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Free Cash Flow (2010 - 2026)

Geron (GERN) posted Free Cash Flow of -$62.9 million for Q1 2026, down 185.07% sequentially from -$22.1 million in Q4 2025, and down 31.11% YoY from -$91.3 million in Q1 2025.

Geron (GERN) Free Cash Flow (2010 - 2026) Analysis & Trends

Geron has reported Free Cash Flow for 17 years, with the latest figure at -$62.9 million in Q1 2026.

  • Quarterly Free Cash Flow fell 31.11% year-over-year to -$62.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$126.0 million (up 38.31% YoY) and the FY2025 annual result came in at -$111.0 million, up 49.37% from the prior year.
  • Free Cash Flow eased to -$62.9 million in Q1 2026 per GERN's latest filing, from -$22.1 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$13.6 million in Q3 2025 and troughed at -$63.1 million in Q1 2024.
  • A 5-year average of -$40.6 million and a median of -$41.0 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2025: Free Cash Flow slumped 109.44% in 2023, then surged 76.97% in 2025.
  • Over 5 years, Free Cash Flow stood at -$35.3 million in 2022, then dropped by 16.08% to -$41.0 million in 2023, then declined by 6.83% to -$43.8 million in 2024, then jumped by 49.62% to -$22.1 million in 2025, then tumbled by 185.07% to -$62.9 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$62.9 million, -$22.1 million, and -$13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Geron 1.02 Mn -299.83 Mn - -15.83 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.83 Mn
Jun 30, 2026 -15.83 Mn
Mar 31, 2026 -62.91 Mn
Mar 31, 2026 -62.91 Mn
Dec 31, 2025 -22.07 Mn
Dec 31, 2025 -22.07 Mn
Sep 30, 2025 -13.58 Mn
Sep 30, 2025 -13.58 Mn
Jun 30, 2025 -27.42 Mn
Jun 30, 2025 -27.42 Mn
Mar 31, 2025 -47.98 Mn
Mar 31, 2025 -47.98 Mn
Dec 31, 2024 -43.80 Mn
Dec 31, 2024 -43.80 Mn
Sep 30, 2024 -58.94 Mn
Sep 30, 2024 -58.94 Mn
Jun 30, 2024 -53.48 Mn
Jun 30, 2024 -53.48 Mn
Mar 31, 2024 -63.07 Mn
Mar 31, 2024 -63.07 Mn